Genpact Ltd
Genpact Ltd operates in various business sectors.
Genpact Ltd (35G) - Net Assets
Latest net assets as of June 2024: €2.34 Billion EUR
Based on the latest financial reports, Genpact Ltd (35G) has net assets worth €2.34 Billion EUR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€5.18 Billion) and total liabilities (€2.84 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.34 Billion |
| % of Total Assets | 45.15% |
| Annual Growth Rate | 9.87% |
| 5-Year Change | 33.11% |
| 10-Year Change | N/A |
| Growth Volatility | 10.12 |
Genpact Ltd - Net Assets Trend (2018–2023)
This chart illustrates how Genpact Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Genpact Ltd (2018–2023)
The table below shows the annual net assets of Genpact Ltd from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €2.25 Billion | +23.12% |
| 2022-12-31 | €1.83 Billion | -3.74% |
| 2021-12-31 | €1.90 Billion | +3.43% |
| 2020-12-31 | €1.83 Billion | +8.59% |
| 2019-12-31 | €1.69 Billion | +20.30% |
| 2018-12-31 | €1.40 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Genpact Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 147.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.09 Billion | 48.27% |
| Other Components | €1.16 Billion | 51.73% |
| Total Equity | €2.25 Billion | 100.00% |
Genpact Ltd Competitors by Market Cap
The table below lists competitors of Genpact Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Morgan Sindall Group PLC
LSE:MGNS
|
$316.21K |
|
Cyxone AB
ST:CYXO
|
$316.24K |
|
CENTURY ALUMINUM
BE:EY3
|
$316.31K |
|
NISSAN CHEMICAL IND - Dusseldorf Stock Exchang
DU:NSC
|
$316.32K |
|
BABW
BATS:BABW
|
$315.64K |
|
TOKIO MARINE
BE:MH6
|
$315.54K |
|
NATURAL GAS SRVCS
BE:NGS
|
$315.48K |
|
FTCFF
PINK:FTCFF
|
$315.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Genpact Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 1,826,158,000 to 2,248,392,000, a change of 422,234,000 (23.1%).
- Net income of 631,255,000 contributed positively to equity growth.
- Dividend payments of 100,014,000 reduced retained earnings.
- Share repurchases of 225,499,000 reduced equity.
- New share issuances of 39,485,000 increased equity.
- Other factors increased equity by 77,007,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €631.25 Million | +28.08% |
| Dividends Paid | €100.01 Million | -4.45% |
| Share Repurchases | €225.50 Million | -10.03% |
| Share Issuances | €39.48 Million | +1.76% |
| Other Changes | €77.01 Million | +3.42% |
| Total Change | €- | 23.12% |
Book Value vs Market Value Analysis
This analysis compares Genpact Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.64x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.46x to 2.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €7.42 | €33.07 | x |
| 2019-12-31 | €8.88 | €33.07 | x |
| 2020-12-31 | €9.70 | €33.07 | x |
| 2021-12-31 | €10.24 | €33.07 | x |
| 2022-12-31 | €9.98 | €33.07 | x |
| 2023-12-31 | €12.53 | €33.07 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Genpact Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 28.08%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.10%
- • Asset Turnover: 0.93x
- • Equity Multiplier: 2.14x
- Recent ROE (28.08%) is above the historical average (20.43%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 20.03% | 9.37% | 0.85x | 2.51x | €140.84 Million |
| 2019 | 18.84% | 8.71% | 0.82x | 2.64x | €149.26 Million |
| 2020 | 16.81% | 8.31% | 0.76x | 2.66x | €124.85 Million |
| 2021 | 19.47% | 9.19% | 0.81x | 2.62x | €179.73 Million |
| 2022 | 19.35% | 8.08% | 0.95x | 2.51x | €170.79 Million |
| 2023 | 28.08% | 14.10% | 0.93x | 2.14x | €406.42 Million |
Industry Comparison
This section compares Genpact Ltd's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.